Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women With Substance Use Disorder in the Immediate Postpartum Period

NARecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

October 11, 2022

Primary Completion Date

March 1, 2026

Study Completion Date

March 1, 2027

Conditions
Substance Use DisordersPregnancy RelatedContraception
Interventions
BEHAVIORAL

MyPath Intervention

MyPath is a novel patient-centered, reproductive planning decision support tool developed by the research team used to facilitate postpartum contraceptive decision-making among women with SUDs. Designed to facilitate high-quality decisions regarding pregnancy and contraception, MyPath helps women a) review their thoughts about pregnancy and children, b) learn about fertility and preconception health and c) prioritize their preferences for various contraceptive method characteristics (e.g. effectiveness, side effects). As such, MyPath uses a patient-centered approach to help women frame their contraceptive decisions in the context of their goals and health and is a critical first step towards addressing reproductive health inequities among women with SUDs.

BEHAVIORAL

Usual care

Standard of Care

Trial Locations (1)

15213

RECRUITING

Magee Womens Hospital of UPMC, Pittsburgh

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Pittsburgh

OTHER